Christopher R. Loose - 16 Feb 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)

Signature
/s/ James P. Abely, Attorney-in-Fact for Christopher R. Loose
Issuer symbol
KRRO
Transactions as of
16 Feb 2022
Net transactions value
-$7,543
Form type
4
Filing time
18 Feb 2022, 15:13:09 UTC
Previous filing
16 Feb 2022
Next filing
23 Feb 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FREQ Common Stock Sale $3,769 -851 -2.2% $4.43* 37,770 16 Feb 2022 Direct F1, F2
transaction FREQ Common Stock Sale $3,774 -900 -2.4% $4.19* 36,870 17 Feb 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Restricted Stock Unit Award $0 +150,000 $0.000000 150,000 17 Feb 2022 Common Stock 150,000 Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units and does not represent discretionary trades by the Reporting Person.
F2 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.29 to $4.54. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F3 This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.00 to $4.48. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
F4 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F5 The restricted stock units will fully vest on July 4, 2023.